Our mission is to ensure the generation of accurate and precise findings.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
At DELSU Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory,
we are unveiling the frontiers of neuroscience and biopsychiatry
Across lifespan, in health and disease states, the cells that make up the brain undergoes changes - neuronal and cellular degenerations, consequently affecting their functions. Research activities being developed in the DELSU Joint Canada-Israel Neuroscience and Biopsychiatry Lab headed by Dr. Ben-Azu Benneth as Principal Investigator, aims to elucidate how multiple epigenetic factors such as stress, diets, infections, and drug abuse affect brain immunity in health and neuropsychiatric states. Our ultimate goal is to design novel therapeutic strategies that specifically target markers of neurochemical changes, oxidative stress, neurotrophism, apoptosis, cellular senescence, and neuroinflammation, including microglia dysfunction, to prevent and treat major neurodevelopmental and neurodegenerative diseases such as schizophrenia, autism, attention deficit hyperactive disease, anxiety- and major depressive disorders, Alzheimer’s and Parkinson's diseases.
Investigating the impacts of epigenetic factors such as diets, stress, addiction, infection and pollution on brain immunity and their role in neuropsychiatric conditions, with a focus to understand the molecular mechanisms underlying neuroinflammation and its contributions to diseases.
Studying the role of neurotrophic factors in promoting neuronal survival and functions, with particular emphasis on their potential as targets for interventions in conditions such as schizophrenia, autism, Alzheimer’s and Parkinson’s diseases.
Investigating neurochemical alterations associated with depression, anxiety disorders and other neuropsychiatric conditions to identify potential targets for novel therapeutic interventions aimed at alleviating symptoms and improving mental health outcomes.
Understanding the impacts of neuroinflammation on brain functions, neuropsychiatric and neurodegenerative diseases, with a focus on elucidating the role of immune responses, notably microglia function, in modulating neuronal activities and their implications for cognitive and emotional well-being.
Investigating the mechanisms of cellular senescence in health and disease states across different age trajectories, with interests in their potential as targets for the development senolytics for interventions in conditions such Alzheimer's disease.
The Delta State University (DELSU) Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory, established with the approval of the Vice Chancellor Prof. Egwunyenga O. Andy, is domiciled at the Department of Pharmacology, Faculty of Basic Medical Sciences, College of Health Sciences, Campus 3, Delta State University, Abraka. The laboratory was approved following the successful award of the Joint Canada-Israel Health Research Project in 2022. Our primary research focus encompasses neuroscience-based experiments, including behavioural studies and biochemical and molecular assays. However, the laboratory is equipped to undertake a wide range of research methodologies. Our investigations at the DELSU Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory aim to elucidate the impact of epigenetic factors on brain development in health and disease states. Specifically, we are elucidating how neuronal and cellular changes and neuroinflammatory-related mechanisms, notably changes in microglia functions, impact development, aging, and disease states, particularly in the context of neuropsychiatric conditions. In line with this, we are always seeking to improve our technical skill sets.
If you have any inquiries, collaboration opportunities, or would like to learn more about our research and services, please feel free to contact us using the form below.
content currently unavailable, please check back
The DELSU Joint Canada-Israel Neuroscience & Biopsychiatry Laboratory at the Faculty of Basic Medical Science, Delta State University (DELSU), is
There are evidences that some persons take alcohol to reduce stress after their daily tasks or adverse situations. Recent studies
Alzheimer’s disease (AD) has continued to cast its socio-economic burden on sufferers and caregivers. This common irreversible neurodegenerative disease with
Posttraumatic stress disorder (PTSD) which is a mental health condition that is triggered by a terrifying event and has a